Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.725 USD | -1.47% | +5.95% | -20.49% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.49% | 1.87B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
-0.20% | 22.02B | |
-17.84% | 20.9B | |
-9.12% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Shares Decline After BofA Securities Downgrade